Keith M. Olson - Concepedia

Author

Keith M. Olson

University of Arizona ORCID

Also Known As

H. Chang, K. Olson, Keith M Olson, Keith M. Olson, Keith Mathew Olson, Keith Olson, Kristofor A. Olson

Publications

315

Citations

H-Index

Concepts

All Affiliations

University of Arizona University of Michigan University of Wisconsin–Green Bay

About

Keith M. Olson is an author at University of Arizona specializing in medicine, health sciences, and pain management.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	131
2	Health Sciences	2	2	97
3	Pharmacology	2	2	97
4	Biochemistry	1	1	44
5	Obstetrics	1	1	34

Keith M. Olson

Publications

276

Citations

H-Index

Page 1

	Year	Citations
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids Keith M. Olson, David I. Duron, Daniel E. Womer, PLoS ONE Opioid EpidemicPain DisordersDrug TargetPain MedicineMolecular Pain	2019	53
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. Keith M. Olson, Wei Lei, Attila Keresztes, PubMed Drug TargetPain MedicineMolecular PainPharmacotherapyMolecular Pharmacology	2017	44
Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice Keith M. Olson, Attila Keresztes, Jenna Tashiro, Journal of Medicinal Chemistry	2018	42
Attitudes to chemotherapy in patients with ovarian cancer Richard T. Penson, Fiona L. Dignan, Michael V. Seiden, Gynecologic Oncology Cancer LiteracyMedicineCancer ManagementGynecologyOncology	2004	34
Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium/calmodulin-dependent protein kinase II signaling Attila Keresztes, Keith M. Olson, Paul Nguyen, Pain	2021	26
In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs Wallace Chan, Keith M. Olson, Jesse W. Wotring, Scientific Reports	2022	26
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain Aswini Kumar Giri, Christopher R. Apostol, Yue Wang, Journal of Medicinal Chemistry	2015	20
Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose Alex Disney, Keith M. Olson, Amanda M. Shafer, ACS Chemical Neuroscience	2022	11
The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice Todd M. Hillhouse, Keith M. Olson, James E. Hallahan, Journal of Pharmacology and Experimental Therapeutics	2021	10
Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice Keith M. Olson, Todd M. Hillhouse, Gwendolyn E. Burgess, Journal of Pharmacology and Experimental Therapeutics	2022	10

Page 1